AutoPathNet: a patient-specific automated 3D trajectory planning framework for minimally invasive evacuation of hypertensive intracerebral hemorrhage.
Authors
Affiliations (2)
Affiliations (2)
- School of Computer Science, Beijing University of Technology, Beijing, China.
- Department of Neurosurgery, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China.
Abstract
Rapid and reproducible trajectory planning is important for minimally invasive evacuation of hypertensive intracerebral hemorrhage (ICH). We developed AutoPathNet, a patient-specific automated 3D trajectory-planning framework that generates geometrically favorable candidate trajectories from preoperative imaging. AutoPathNet reconstructs patient-specific anatomical models from CT-derived inputs, generates candidate entry-target trajectories, filters candidates according to predefined anatomical constraints, and ranks feasible trajectories using a composite geometric planning metric. Algorithm-generated trajectories were compared with surgeon-implemented catheter trajectories reconstructed from postoperative CT in a 21-patient validation cohort. The framework generated three candidate trajectories within approximately 31 s. In 16 of 21 paired cases (76.2%; Wilson 95% confidence interval, 54.9%-89.4%), the best algorithm-generated candidate had a lower <i>m</i> value than the surgeon-implemented catheter trajectory reconstructed from postoperative CT. This comparison uses postoperative catheter position as a procedural imaging reference and reflects geometric planning performance within the current constraint model, suggesting potential value as a neurosurgeon-supervised planning reference rather than evidence of clinical outcome superiority. AutoPathNet rapidly generated patient-specific candidate trajectories for minimally invasive evacuation of hypertensive ICH. The framework may support neurosurgeon-supervised trajectory planning, but prospective validation using multimodal functional constraints and clinical outcome endpoints is required before clinical deployment.